Economic Impacts and Quality of Life for Caregivers of Patients with Retinitis Pigmentosa: A Cross-Sectional Japanese Study

Retinitis pigmentosa (RP) is the second leading cause of visual impairment in Japan and causes progressive vision loss in affected patients. Caregiving for patients with RP is associated with socioeconomic impacts; however, data on the magnitude and scope of these impacts are lacking. This cross-sectional study surveyed informal caregivers of patients with RP in Japan. The questionnaire assessed the socioeconomic status of participants; work impacts through the Work Productivity and Activity Impairment Questionnaire adapted for caregivers; and quality of life impacts through the Japanese version of the Caregiver Reaction Assessment (CRA) and the 5-level EQ-5D version (EQ-5D-5L). Of the 37 participating caregivers, 28 (75.7%) were employed. Among those, the average annual income was 2,722,080 yen (n = 20) and the mean loss of work productivity was 6.6%. The mean EQ-5D-5L index score was 0.882, and the mean CRA total score was 2.1. A mild to very severe impact on family life, leisure and hobbies, social life, and mental health was experienced by 83.8%, 78.4%, 75.7%, and 70.3%, respectively. These results suggest that caregivers of patients with RP may be disadvantaged in terms of employment and income and may experience wide-ranging impacts on their quality of daily life.

[1]  Cécile van Steen,et al.  Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs , 2022, Clinical ophthalmology.

[2]  K. Prescott,et al.  Valuation of Lost Productivity in Caregivers: A Validation Study , 2021, Frontiers in Psychology.

[3]  Nan Li,et al.  The Burden of X-Linked Retinitis Pigmentosa on Patients and Society: A Narrative Literature Review , 2021, ClinicoEconomics and outcomes research : CEOR.

[4]  T. Fukuda,et al.  Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings. , 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  B. Crawford,et al.  Family caregiver burden of patients with osteoporotic fracture in Japan , 2021, Journal of Bone and Mineral Metabolism.

[6]  Yirong Chen,et al.  Humanistic burden among caregivers of patients with Alzheimer’s disease or dementia in Japan: a large-scale cross-sectional survey , 2021, Journal of medical economics.

[7]  Yirong Chen,et al.  Humanistic and economic burden among caregivers of patients with cancer in Japan , 2020, Journal of medical economics.

[8]  M. Harris,et al.  Employment disadvantage and associated factors for informal carers of adults with mental illness: are they like other disability carers? , 2019, BMC Public Health.

[9]  Abigail T. Fahim Retinitis pigmentosa: recent advances and future directions in diagnosis and management , 2018, Current opinion in pediatrics.

[10]  H. Yamashita,et al.  Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals , 2018, Japanese Journal of Ophthalmology.

[11]  A. Igarashi,et al.  Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey , 2017, Journal of market access & health policy.

[12]  Gretchen A. Stevens,et al.  Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. , 2017, The Lancet. Global health.

[13]  Takashi Fukuda,et al.  Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  R. Maguire,et al.  Examining the role of subjective and objective burden in carer health-related quality of life: the case of colorectal cancer , 2015, Supportive Care in Cancer.

[15]  S. Sivaprasad,et al.  Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration , 2015, PloS one.

[16]  Takashi Fukuda,et al.  Developing a Japanese version of the EQ-5D-5L value set , 2015 .

[17]  R. Adelman,et al.  Caregiver burden: a clinical review. , 2014, JAMA.

[18]  W. Nelson,et al.  Factors associated with ‘caregiver burden’ for atrial fibrillation patients , 2012, International journal of clinical practice.

[19]  C. Boult,et al.  Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patients. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  M. Miyashita,et al.  Validity and Reliability of the Japanese Version of the Caregiver Reaction Assessment Scale (CRA-J) for Community-Dwelling Cancer Patients , 2009, The American journal of hospice & palliative care.

[21]  A. While,et al.  Informal carer activities, carer burden and health status in multiple sclerosis , 2007, Clinical rehabilitation.

[22]  H. Boshuizen,et al.  Dimension-specific burden of caregiving among partners of rheumatoid arthritis patients. , 2003, Rheumatology.

[23]  L. Gunning-Schepers,et al.  Caring for relatives with dementia — Caregiver experiences of relatives of patients on the waiting list for admission to a psychogeriatric nursing home in The Netherlands , 2001, Scandinavian journal of public health.

[24]  A. Zbrozek,et al.  The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.